CorVent Medical Expands into New Office, Adding 13,000+ Space
Fargo, ND (April 18,2024) – Medical device company, CorVent Medical, is announcing an expansion into a new facility in Fargo.
A press conference and ribbon cutting event will be held to celebrate the new, much larger, facility on April 24th at 3:00 p.m. at 4837 Amber Valley Pkwy S.
CorVent Medical Expansion
Grand Opening & Ribbon Cutting Ceremony
Wednesday, April 24
3:00 p.m.
4837 Amber Valley Pkwy S.
Fargo, ND
After two years in the market, Corvent Medical’s expansion will add 13,800 additional square feet and additional staff. The additional space will support R&D, marketing, quality and regulatory affairs. The company is also transferring manufacturing from California to Fargo.
CorVent™ Medical develops and manufactures smart, versatile, lifesaving breathing technologies for Hospitals, Home, Sub-Acute care centers and Skilled Nursing facilities. FDA clearance of the Respond™ ventilator is pending, and in anticipation of high customer demand, the company is opening its brand-new state of the art Med Tech facility which will house Engineering, Manufacturing, and worldwide operations into a single facility. This new facility will be one of only a couple US owned and operated Ventilation Companies and will allow us to grow the company while leveraging the talent of Fargo’s diverse workforce.
“We are delighted to be a part of the greater Fargo community and look forward to leading the way with the growing movement for medical device innovation in North Dakota. The unwavering support from the GFMEDC, Dept of Agriculture, Dept of Commerce, Pioneer Capital Fund, Starion Bank and the Bioscience Association of North Dakota has been instrumental in our success and has helped make this new facility possible” said Richard S. Walsh, President and CEO of CorVent Medical
The GFMEDC has been working with CorVent Medical since the first half of 2021 to connect the company to competitive capital, resources, programing, talent, and more.
“CorVent is innovating to improve lifesaving technologies and we are extremely excited that the team at CorVent has decided to continue to expand their business here in our region and bet on their future growth here,” said Joe Raso, President and CEO of the GFMEDC. “CorVent’s commitment to the region is further evidence of the increasing momentum we are building in the bioscience and medical device industries. CorVent is a strong partner and a leader among the increasing number of medical device companies we have added to the ecosystem in recent years.”
About CorVent Medical
CorVent Medical, a privately held medical device startup, is committed to developing versatile, lifesaving ventilators for critical care. The company’s first product, the RESPOND-19™ Ventilator, provides ICU-quality respiratory support that expands ventilation capacity with reliable and affordable deployment when you need it most. The streamlined system enables sophisticated ventilation that includes lifesaving, life sustaining and weaning capabilities with excellent infection control. The robust, lightweight system eliminates the need for costly service and maintenance plans and was designed and built in the USA. To learn more, please visit www.corventmedical.com.
About the GFMEDC
The core purpose of the GFMEDC is to cultivate an economic environment where all people and organizations flourish. www.GFMEDC.com
